A5046307144- Human Health and Disease
- Hemophilia Treatment and Research
- Iron Metabolism and Disorders
- Healthcare Systems and Public Health
- Healthcare and Venom Research
- Hemoglobinopathies and Related Disorders
- Diet and metabolism studies
- Health and Medical Research Impacts
- Child and Adolescent Health
- Biomedical and Engineering Education
- Rabbits: Nutrition, Reproduction, Health
- Erythropoietin and Anemia Treatment
- Historical Medical Research and Treatments
- Adipose Tissue and Metabolism
- Global Healthcare and Medical Tourism
- Birth, Development, and Health
- Infant Nutrition and Health
Ministry of Health of the Russian Federation
2019
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
2012-2019
The implementation of the state program “7 highcost nosologies” and active work Russian hematologists have significantly improved specialized care for children adults with Hemophilia. hemophilia patient registry as 10.25.2018 contained information about 7433 patients, whom A – 6525 people. About 400 people were diagnosed inhibitors. inhibitor predominantly appeared at child young age (up to 20 years). There is a high supply coagulation factors concentrates treatment in Federation 8.1 IU...
В статье описана история интеграции клинической фармакологии в обеспечение качества лечебного процесса на базе клиники Южно-Уральского государственного медицинского универ- ситета Минздрава России. Подчеркнута роль и понимание главными врачами места развитии базы, создание специализированного отделения последующем Центра «Персонализированной медицины» с целью реализации современной концепции здравоохранения 4П, освоения нового направления – фармакогенетики. Опи- сана научная деятельность,...
The aim of the study was to evaluate efficacy, safety and pharmacokinetics nonacog alfa (Innonafactor) in children aged 2 12 years with hemophilia B. Materials methods: 15 patients (7.7±2.5 ) were included an open, multicenter, prospective, non-comparative clinical trial, whom 6 3 years. efficacy drug assessed against background introduction 45±10 IU/kg times a week interval 72–96 hours, by frequency nature adverse reactions. Results: 5 (22%) spontaneous 18 (78%) post-traumatic bleedings...
Premature infants are referred to the specific risk group for developing iron deficiency anemia (IDA). Depending on time of occurrence and pathogenetic mechanisms, in premature is classified into several types among which only late characterized by deficiency. The article tells about causes development mechanisms IDA infants, as well methods prevention treatment. focus babies through administration preparations.
<h3>Background and Aims</h3> Adolescents form a group at risk of iron deficiency development. An additional factor leading to depletion stores in adolescent girls is blood loss during menstrual bleeding. <h3>Methods</h3> A cross-sectional nonrandomized descriptive study was carried out order evaluate the incidence dysfunctional uterine bleeding (DUB) detect relationship between anemia, develop measures improve health status adolescents. The within routine examination schoolchildren Vologda....
Providing hemophilia patients with blood coagulation preparations is one of the priority tasks national health care system. In 2011, first recombinant factor IX was created in Russia (rFIX, nonacog alpha, Innonafactor, GENERIUM JSC), that previously studied for pharmacokinetic (PK) parameters, efficacy and safety adult adolescents over 12 years age severe moderate B. Objective this open-label, prospective, multicenter, noncomparative clinical study to PK, Innonafactor aged 6 forms B (FIX...